Jazz Pharmaceuticals, Inc. (JAZZ) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "JAZZ"
      ],
      "issuer_cik": "0001232524",
      "owner_cik": "0001607737",
      "accession_number": "0001607737-26-000016",
      "form_type": "4",
      "filing_date": "2026-10-07",
      "period_of_report": "2026-10-06",
      "issuer_name": "Jazz Pharmaceuticals plc",
      "issuer_trading_symbol": "JAZZ",
      "owner_name": "GALA RENEE D",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "President & CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-06",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 2000,
      "transaction_price_per_share": 236.4,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 141394,
      "transaction_value": 472800,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."
        }
      ]
    },
    {
      "tickers": [
        "JAZZ"
      ],
      "issuer_cik": "0001232524",
      "owner_cik": "0001193210",
      "accession_number": "0001193210-26-000028",
      "form_type": "4",
      "filing_date": "2026-10-05",
      "period_of_report": "2026-10-01",
      "issuer_name": "Jazz Pharmaceuticals plc",
      "issuer_trading_symbol": "JAZZ",
      "owner_name": "COZADD BRUCE C",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Ordinary Shares",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-10-01",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 6000,
      "transaction_price_per_share": 230.33,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 345875,
      "transaction_value": 1381980,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.